Even as regulators seek a more streamlined process for supplements in China, investors, retailers, and customers continue to focus on cross-border e-commerce.
Dietary supplement prospectors in the U.S. have long heard about the rich opportunities coming out of China’s emerging market. Here in 2018, what do those business opportunities really look like?
With China’s Food and Drug Administration (CFDA) still struggling to smooth the regulatory process for dietary supplements, China’s domestic supplement players are focusing heavily on cross-border investment and e-commerce, creating attractive opportunities for international brands.
Nutritional Outlook learned about some of the biggest market opportunities and regulatory challenges facing the China supplement market today from Jeff Crowther, executive director of the U.S.-China Health Products Association (USCHPA), an organization committed to promoting the commerce of health products in China. Here’s what we found out.
CLICK ON IMAGES TO VIEW SLIDESHOW
Photo © iStockphoto.com